1996
DOI: 10.1002/(sici)1096-911x(199604)26:4<284::aid-mpo13>3.0.co;2-f
|View full text |Cite
|
Sign up to set email alerts
|

Pancreatic blastomatous tumor in a child responding to therapy used for hepatoblastoma: Case report and review of the literature

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
6
0
2

Year Published

2002
2002
2021
2021

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 10 publications
(8 citation statements)
references
References 19 publications
0
6
0
2
Order By: Relevance
“…Pancreatoblastoma shares similar histologic and morphologic features with hepatoblastoma including secretion of a-fetoprotein [11]. In addition, it appears to affect a similar age group and it is generally responsive to the same chemotherapeutic agents (high risk Hepatoblastoma protocol) with a satisfactory clinical response [11]. Pancreatoblastoma can be associated with Beckwith-Wiedemann syndrome [12].…”
Section: Discussionmentioning
confidence: 99%
“…Pancreatoblastoma shares similar histologic and morphologic features with hepatoblastoma including secretion of a-fetoprotein [11]. In addition, it appears to affect a similar age group and it is generally responsive to the same chemotherapeutic agents (high risk Hepatoblastoma protocol) with a satisfactory clinical response [11]. Pancreatoblastoma can be associated with Beckwith-Wiedemann syndrome [12].…”
Section: Discussionmentioning
confidence: 99%
“…Pancreatic tumours are rarely encountered in paediatric practice. AFP is an important tumour marker in pancreatoblastoma, the commonest malignant paediatric pancreatic tumour [1][2][3]. Its association is also documented in acinar cell tumours of the pancreas [4,5].…”
Section: Discussionmentioning
confidence: 99%
“…
Alpha-fetoprotein (AFP) is a valuable marker for the detection and follow-up of germ cell and hepatic neoplasms. Although the literature is replete with reports of AFP-secreting pancreatic tumours, this association is often forgotten [1][2][3][4][5]. This is especially likely when the clinical picture and laboratory data lead in another direction, as they did in the case of a 13-year old boy who came under our care.
…”
mentioning
confidence: 99%
“…Она име-ет некоторые сходства, в том числе морфологи-ческие, с гепатобластомой и встречается в одной возрастной группе. Обе опухоли обычно наблю-даются в ассоциации с синдромом Беквита-Видемана и часто демонстрируют повышенный уровень альфа-фетопротеина (АФП) в плазме крови [7][8][9][10][11]. Имеются значительные сходства и на молекулярно-генетическом уровне, такие как потеря гетерозиготности 11p15.5, гиперэк-спрессия инсулиноподобного фактора роста-2 (Insulin-like growth factor 2, IGF2) и мутация гена бета-катенина [12].…”
unclassified
“…Общая выживаемость достига-ет 80% у детей с полностью резектабельными опу-холями на момент постановки диагноза [19]. При наличии отдаленных метастазов (обычно в печени или скелете) результаты неблагоприятны [11,15,20]. Опубликовано много работ, где химиотерапия, особенно цисплатинсодержащие схемы, приводи-ла к уменьшению опухолевой массы [11,[21][22][23][24][25].…”
unclassified